NCT06818968View on ClinicalTrials.gov

A Study of the Effect of Multiple Doses of Diltiazem on the Plasma Levels of MK-6916 in Healthy Participants (MK-6916-005)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 27, 2025

Primary Completion Date

August 8, 2025

Study Completion Date

August 8, 2025

Conditions

Healthy

Interventions

DRUG

MK-6916

Oral administration

DRUG

Diltiazem

Oral administration

Trial Locations (1)

53704

Fortrea CRU, Madison ( Site 0001), Madison

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT06818968 - A Study of the Effect of Multiple Doses of Diltiazem on the Plasma Levels of MK-6916 in Healthy Participants (MK-6916-005) | Biotech Hunter | Biotech Hunter